N-phenylquinazolin-4-amine-based EGFR TKIs suppress pulmonary fibrosis by modulating the EGFR/ERBB3 axis in epithelial–macrophage interaction. - Kim, Ji-Hee; Choi, Seo-Hyun; Nam, Jae-Kyung; Park, Min-sik; Seo, Haeng Ran; Choi, Inhee; Lee, Hae-June; Cho, Jaeho; Lee, Jeeyong; Lee, Yoon-Jin (Communications Biology, 2025)